Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
AZZ Inc
AZZ
$4.35B
| $673K | ﹤0.01% |
+8,700
| New | +$588K |
|
|
NEXN
2727
Nexxen International
NEXN
$573M
| $673K | ﹤0.01% |
128,900
+5,100
| +4% | +$25.7K |
|
2728
ASP Isotopes
ASPI
$504M
| $672K | ﹤0.01% |
162,600
+87,832
| +117% | +$271K |
|
|
CODX
2729
Co-Diagnostics
CODX
$5.31M
| $672K | ﹤0.01% |
20,013
-554
| -3% | -$20.1K |
|
2730
Nortech Systems
NSYS
$37.8M
| $671K | ﹤0.01% |
50,259
-700
| -1% | -$7.73K |
|
2731
dLocal
DLO
$4.44B
| $670K | ﹤0.01% |
45,589
-163,411
| -78% | -$2.73M |
|
2732
Telecom Argentina
TEO
$6.03B
| $668K | ﹤0.01% |
84,077
+6,190
| +8% | +$45.7K |
|
|
WOW
2733
DELISTED
WideOpenWest
WOW
| $668K | ﹤0.01% |
184,500
+33,800
| +22% | +$121K |
|
|
NRGD
2734
DELISTED
MicroSectors US Big Oil -3x Inverse Leveraged ETN
NRGD
| $666K | ﹤0.01% |
4,600
+3,400
| +283% | +$699K |
|
2735
Gildan
GIL
$10.3B
| $665K | ﹤0.01% |
17,900
-80,000
| -82% | -$2.72M |
|
2736
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.22B
| $663K | ﹤0.01% |
15,900
+10,000
| +169% | +$403K |
|
2737
Good Times Restaurants
GTIM
$14.6M
| $662K | ﹤0.01% |
268,183
-3,695
| -1% | -$9.2K |
|
2738
ImmuCell
ICCC
$101M
| $662K | ﹤0.01% |
124,889
-1,300
| -1% | -$6.7K |
|
2739
MeiraGTx Holdings
MGTX
$1.09B
| $662K | ﹤0.01% |
109,100
+28,700
| +36% | +$181K |
|
2740
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $661K | ﹤0.01% |
4,300
-100
| -2% | -$15.2K |
|
2741
ACNB Corp
ACNB
$656M
| $660K | ﹤0.01% |
17,556
+500
| +3% | +$19.5K |
|
|
MDV
2742
Modiv Industrial
MDV
$179M
| $658K | ﹤0.01% |
39,200
+13,425
| +52% | +$201K |
|
|
SAGE
2743
DELISTED
Sage Therapeutics
SAGE
| $658K | ﹤0.01% |
+35,100
| New | +$810K |
|
2744
Leonardo DRS
DRS
$12.3B
| $654K | ﹤0.01% |
29,600
-40,900
| -58% | -$850K |
|
2745
RB Global
RBA
$20.4B
| $654K | ﹤0.01% |
8,584
+3,184
| +59% | +$222K |
|
2746
Usio Inc
USIO
$58.8M
| $654K | ﹤0.01% |
384,741
-400
| -0.1% | -$684 |
|
2747
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.9B
| $653K | ﹤0.01% |
15,600
-46,600
| -75% | -$1.9M |
|
2748
IBEX
IBEX
$473M
| $653K | ﹤0.01% |
42,300
-22,800
| -35% | -$374K |
|
2749
Identive
INVE
$63.4M
| $652K | ﹤0.01% |
82,382
-1,500
| -2% | -$12K |
|
2750
Century Therapeutics
IPSC
$364M
| $652K | ﹤0.01% |
156,000
+36,800
| +31% | +$156K |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.